Kiniksa Pharmaceuticals International (KNSA) P/S ratio

P/S ratio today
11.1×

Kiniksa Pharmaceuticals International (KNSA) trades at 11.1× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 4.8×. That is 44.0% higher than the 3.3× of fiscal 2024. Figures as of 18 Nov 2026, 07:11 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
11.1×
P/S ratio, fiscal 2025
4.8×
Change on fiscal 2024
+44.0%
Highest on record
20.9×fiscal 2021
Lowest on record
3.3×fiscal 2024
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Kiniksa Pharmaceuticals International P/S ratio, in more detail

Today's figure is 130.6% above the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2021–2025), the highest was 20.9× in fiscal 2021 and the lowest 3.3× in fiscal 2024. Today's P/S ratio is higher than at 80% of the 5 fiscal year-ends on record; their median is 4.8×.

History · 5 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Kiniksa Pharmaceuticals International P/S ratio, year by year

Kiniksa Pharmaceuticals International (KNSA) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today11.1×—$95.11—
20254.8× 44.0% up$41.25$8.58
20243.3× 28.5% down$19.78$5.93
20234.7× 2.6% down$17.54$3.76
20224.8× 77.1% down$14.98$3.13
202120.9×—$11.77$0.56
2020——$17.67—
2019——$11.06—
2018——$28.09—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Kiniksa Pharmaceuticals International and comparable companies
CompanyP/S ratio
Alkermes ALKS5.2×
PACS Group PACS1.5×
Kiniksa Pharmaceuticals International KNSA11.0×
ImmunityBio IBRX58.8×
Cytokinetics CYTK81.7×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on KNSA

Kiniksa Pharmaceuticals International, figure by figure

Kiniksa Pharmaceuticals International (KNSA) overview: price, valuation and scorecardAll health care companies by market value

Kiniksa Pharmaceuticals International P/S ratio: questions and answers

What is Kiniksa Pharmaceuticals International's P/S ratio?

Kiniksa Pharmaceuticals International (KNSA) trades at 11.1× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 4.8×. That is 44.0% higher than the 3.3× of fiscal 2024.

Is Kiniksa Pharmaceuticals International's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 80% of the 5 fiscal year-ends on record; their median is 4.8×.

What are the highest and lowest P/S ratio figures on record for Kiniksa Pharmaceuticals International?

Across the 5 fiscal year-ends on record (2021–2025), the highest was 20.9× in fiscal 2021 and the lowest 3.3× in fiscal 2024.

How is Kiniksa Pharmaceuticals International's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kiniksa Pharmaceuticals International (KNSA) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/KNSA/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.